Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.

Shealy DJ, Cai A, Staquet K, Baker A, Lacy ER, Johns L, Vafa O, Gunn G 3rd, Tam S, Sague S, Wang D, Brigham-Burke M, Dalmonte P, Emmell E, Pikounis B, Bugelski PJ, Zhou H, Scallon BJ, Giles-Komar J.

MAbs. 2010 Jul-Aug;2(4):428-39. Epub 2010 Jul 1.

2.

Free sulfhydryl measurement as an indicator of antibody stability.

Lacy ER, Baker M, Brigham-Burke M.

Anal Biochem. 2008 Nov 1;382(1):66-8. doi: 10.1016/j.ab.2008.07.016. Epub 2008 Jul 26.

PMID:
18675772
3.

Down modulation of human TLR3 function by a monoclonal antibody.

Duffy KE, Lamb RJ, San Mateo LR, Jordan JL, Canziani G, Brigham-Burke M, Korteweg J, Cunningham M, Beck HS, Carton J, Giles-Komar J, Duchala C, Sarisky RT, Mbow ML.

Cell Immunol. 2007 Aug;248(2):103-14. Epub 2007 Nov 28.

PMID:
18048020
4.

Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.

Tornetta M, Fisher D, O'Neil K, Geng D, Schantz A, Brigham-Burke M, Lombardo D, Fink D, Knight D, Sweet R, Tsui P.

J Immunol Methods. 2007 Dec 1;328(1-2):34-44. Epub 2007 Sep 4.

PMID:
17888945
5.

Engineering human IL-18 with increased bioactivity and bioavailability.

Swencki-Underwood B, Cunningham MR, Heavner GA, Blasie C, McCarthy SG, Dougherty T, Brigham-Burke M, Gunn GR, Goletz TJ, Snyder LA.

Cytokine. 2006 Apr;34(1-2):114-24.

PMID:
16750378
6.

An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin.

Ryan MH, Heavner GA, Brigham-Burke M, McMahon F, Shanahan MF, Gunturi SR, Sharma B, Farrell FX.

Int Immunopharmacol. 2006 Apr;6(4):647-55. Epub 2005 Nov 14.

PMID:
16504928
7.

Synthesis and biological characterization of human monocyte chemoattractant protein 1 (MCP-1) and its analogs.

Kruszynski M, Stowell N, Das A, Seideman J, Tsui P, Brigham-Burke M, Nemeth JF, Sweet R, Heavner GA.

J Pept Sci. 2006 Jan;12(1):25-32.

PMID:
15942931
8.

A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody.

Fisher PW, Brigham-Burke M, Wu SJ, Luo J, Carton J, Staquet K, Gao W, Jackson S, Bethea D, Chen C, Hu B, Giles-Komar J, Yang J.

Biochem J. 2005 May 1;387(Pt 3):727-35.

9.

Selective binding and oligomerization of the murine granulocyte colony-stimulating factor receptor by a low molecular weight, nonpeptidyl ligand.

Doyle ML, Tian SS, Miller SG, Kessler L, Baker AE, Brigham-Burke MR, Dillon SB, Duffy KJ, Keenan RM, Lehr R, Rosen J, Schneeweis LA, Trill J, Young PR, Luengo JI, Lamb P.

J Biol Chem. 2003 Mar 14;278(11):9426-34. Epub 2003 Jan 10.

10.

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.

Hart TK, Blackburn MN, Brigham-Burke M, Dede K, Al-Mahdi N, Zia-Amirhosseini P, Cook RM.

Clin Exp Immunol. 2002 Oct;130(1):93-100.

11.

Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT.

Cytokine. 2002 Apr 21;18(2):61-71.

PMID:
12096920
12.

Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells.

Khandekar SS, Silverman C, Wells-Marani J, Bacon AM, Birrell H, Brigham-Burke M, DeMarini DJ, Jonak ZL, Camilleri P, Fishman-Lobell J.

Protein Expr Purif. 2001 Nov;23(2):301-10.

PMID:
11676606
13.

Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid.

Lavulo LT, Sossong TM Jr, Brigham-Burke MR, Doyle ML, Cox JD, Christianson DW, Ash DE.

J Biol Chem. 2001 Apr 27;276(17):14242-8. Epub 2001 Jan 24.

14.

Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees.

Newman R, Hariharan K, Reff M, Anderson DR, Braslawsky G, Santoro D, Hanna N, Bugelski PJ, Brigham-Burke M, Crysler C, Gagnon RC, Dal Monte P, Doyle ML, Hensley PC, Reddy MP, Sweet RW, Truneh A.

Clin Immunol. 2001 Feb;98(2):164-74.

PMID:
11161972
15.

Measurement of protein interaction bioenergetics: application to structural variants of anti-sCD4 antibody.

Doyle ML, Brigham-Burke M, Blackburn MN, Brooks IS, Smith TM, Newman R, Reff M, Stafford WF 3rd, Sweet RW, Truneh A, Hensley P, O'Shannessy DJ.

Methods Enzymol. 2000;323:207-30.

PMID:
10944754
16.

Evaluating energetics of erythropoietin ligand binding to homodimerized receptor extracellular domains.

Hensley P, Doyle ML, Myszka DG, Woody RW, Brigham-Burke MR, Erickson-Miller CL, Griffin CA, Jones CS, McNulty DE, O'Brien SP, Amegadzie BY, MacKenzie L, Ryan MD, Young PR.

Methods Enzymol. 2000;323:177-207. No abstract available.

PMID:
10944753
17.

Energetics of the HIV gp120-CD4 binding reaction.

Myszka DG, Sweet RW, Hensley P, Brigham-Burke M, Kwong PD, Hendrickson WA, Wyatt R, Sodroski J, Doyle ML.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9026-31.

18.

Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4.

Reddy MP, Kinney CA, Chaikin MA, Payne A, Fishman-Lobell J, Tsui P, Dal Monte PR, Doyle ML, Brigham-Burke MR, Anderson D, Reff M, Newman R, Hanna N, Sweet RW, Truneh A.

J Immunol. 2000 Feb 15;164(4):1925-33.

19.

Secondary structure and structure-activity relationships of peptides corresponding to the subunit interface of herpes simplex virus DNA polymerase.

Bridges KG, Hua Q, Brigham-Burke MR, Martin JD, Hensley P, Dahl CE, Digard P, Weiss MA, Coen DM.

J Biol Chem. 2000 Jan 7;275(1):472-8.

20.

Self-activation of guanosine triphosphatase activity by oligomerization of the bacterial cell division protein FtsZ.

Sossong TM Jr, Brigham-Burke MR, Hensley P, Pearce KH Jr.

Biochemistry. 1999 Nov 9;38(45):14843-50.

PMID:
10555966
21.

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.

Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P, DiPrinzio R, Emery JG, Deen K, Eichman C, Chabot-Fletcher M, Truneh A, Young PR.

J Biol Chem. 1998 Oct 16;273(42):27548-56.

22.

Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.

Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, Tan KB, Silverman C, Eichman C, DiPrinzio R, Spampanato J, Porter T, Holmes S, Young PR, Truneh A.

J Immunol. 1998 Aug 15;161(4):1786-94.

23.

Detection and quantitation of hexa-histidine-tagged recombinant proteins on western blots and by a surface plasmon resonance biosensor technique.

O'Shannessy DJ, O'Donnell KC, Martin J, Brigham-Burke M.

Anal Biochem. 1995 Jul 20;229(1):119-24.

PMID:
8533880
24.

A general method to recondition and reuse BIAcore sensor chips fouled with covalently immobilized protein/peptide.

Chatelier RC, Gengenbach TR, Griesser HJ, Brigham-Burke M, O'Shannessy DJ.

Anal Biochem. 1995 Jul 20;229(1):112-8.

PMID:
8533879
25.

Biological and biophysical characterization of recombinant soluble human E-selectin purified at large scale by reversed-phase high-performance liquid chromatography.

Burrows SD, Franklin SG, Brigham-Burke MR, Brooks IS, McNulty DE, Feild JA, Anumula KR, O'Shannessy DJ.

J Chromatogr B Biomed Appl. 1995 Jun 23;668(2):219-31.

PMID:
7581857
26.

Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance.

Plant AL, Brigham-Burke M, Petrella EC, O'Shannessy DJ.

Anal Biochem. 1995 Apr 10;226(2):342-8.

PMID:
7793636
27.

Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance.

O'Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P, Brooks I.

Methods Enzymol. 1994;240:323-49. No abstract available.

PMID:
7823837
28.
29.

Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector.

O'Shannessy DJ, Brigham-Burke M, Peck K.

Anal Biochem. 1992 Aug 15;205(1):132-6.

PMID:
1443550
30.

Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction.

Brigham-Burke M, Edwards JR, O'Shannessy DJ.

Anal Biochem. 1992 Aug 15;205(1):125-31.

PMID:
1443549
31.

Recognition properties of antisense peptides to Arg8-vasopressin/bovine neurophysin II biosynthetic precursor sequences.

Fassina G, Zamai M, Brigham-Burke M, Chaiken IM.

Biochemistry. 1989 Oct 31;28(22):8811-8.

PMID:
2605222

Supplemental Content

Loading ...
Support Center